We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Findings of Canadian Mammography Study Disputed by American Radiology and Breast Imaging Societies

By HospiMedica International staff writers
Posted on 25 Feb 2014
A new study reveals that annual mammography failed to reduce breast cancer mortality in women compared with physical examination or routine care.

Researchers at the University of Toronto School of Public Health (Canada) reviewed 25-year follow-up data of the Canadian National Breast Screening Study (CNBSS), and compared breast cancer incidence in women who did or did not undergo mammography screening. More...
Study participants included 89,835 women (aged 40–59), randomly assigned to mammography (five annual mammography screens) or control (no mammography). Women in their 40’s in the mammography arm and all women in their 50’s in both arms received annual physical breast examinations.

The results showed that during the entire study, 3,250 women in the mammography group developed breast cancer, compared with 3,133 in the control group; 500 deaths due to breast cancer occurred in the screened patients versus 505 in the control group, resulting in a hazard ratio (HR) of 0.99. After 15 years of follow-up, a residual excess of 106 cancers was observed in the mammography arm, attributable to over-diagnosis. The study was published on February 11, 2014, in BMJ.

“Although the difference in survival after a diagnosis of breast cancer was significant between those cancers diagnosed by mammography alone and those diagnosed by physical examination screening, this is due to lead time, length of time bias, and overdiagnosis,” concluded lead author Anthony Miller, MD, and colleagues. “Overall, 22% of screen detected invasive breast cancers were over-diagnosed, representing one over-diagnosed breast cancer for every 424 women who received mammography screening in the trial.”

The study drew a quick response from the American College of Radiology (ACR; Reston, VA, USA) and the Society of Breast Imaging (SBI; Reston, VA, USA). In a joint statement, the two organizations characterized the results as an “Incredibly misleading analysis based on the deeply flawed and widely discredited CNBSS.” According to the ACR/SBI statement, the 32% rate of cancer detection by mammography is an extremely low number consistent with poor-quality mammography, and that mammography alone should detect twice that many cancers.

The organizations also noted that a prior outside review of the CNBSS confirmed the poor quality of mammography in the study. The ACR/SBI statement also questioned the randomization process used by CNBSS, pointing out that all women had a clinical breast examination prior to allocation, providing investigators with advance knowledge about which patients had breast lumps or enlarged lymph nodes.

Related Links:

University of Toronto School of Public Health
American College of Radiology
Society of Breast Imaging



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical-Grade Display
HL2316SHTB
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.